Spencerport, NY, United States of America

Robert Franco

This inventor holds 4 USPTO granted patents. Top assignees: Oncogene Science, Inc., Osi Pharmaceuticals, Inc.. Active years: 1997-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Franco. Retrieved from https://idiyas.com/inventor/robert-franco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 88(Granted Patents)


Company Filing History:


Years Active: 1997-2003

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Robert Franco

Introduction

Robert Franco is an accomplished inventor based in Spencerport, NY (US). He has made significant contributions to the field of gene expression modulation, holding a total of four patents. His work focuses on methods that enhance the understanding and manipulation of gene expression, which can have profound implications in various biological and medical applications.

Latest Patents

Franco's latest patents include innovative methods for preparing compositions comprising chemicals capable of transcriptional modulators. One of his notable inventions provides a method for transcriptionally modulating the expression of a gene of interest. This method involves contacting a cell capable of expressing the gene with a molecule that effectively modulates the gene's expression, thereby influencing the protein levels encoded by that gene. The molecules used in this invention are characterized by their unique properties, such as not naturally occurring in the cell and specifically modulating gene expression.

Another significant patent by Franco outlines methods for discovering chemicals that can function as gene expression modulators. This invention also involves contacting a cell with a molecule that can transcriptionally modulate gene expression. The molecules in this patent are defined by their ability to bind to DNA or RNA or interact with proteins in a specific manner that does not involve the natural ligand binding domains of receptors.

Career Highlights

Throughout his career, Robert Franco has worked with prominent companies in the biotechnology sector, including Oncogene Science, Inc. and Osi Pharmaceuticals, Inc.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…